The combination of TAGLN/HDAC2 blocker and natural borneol for treating GBM patients reveals that combined traditional Chinese and Western medicine enhance the delivery of sodium valproate into GBM tumors and improve preclinical efficacy. The gene discussed is TAGLN; the disease is glioblastoma.